Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of LISA and INSURE Methods for Surfactant Administration in Preterm Infants With RDS
NCT07910539Completed
- Sponsor
- Fatima Jinnah Medical University
- Start
- May 2023
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Randomised, open-label trial of Poractant alfa in respiratory distress syndrome (RDS) (2 arms), sponsored by Fatima Jinnah Medical University. Primary endpoint: Need for Mechanical Ventilation at 3 hours. Started May 2023; status: completed.
02
Drugs
Poractant alfa
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT07910539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07910539.